HealthTronics to Buy Endocare

HealthTronics announced that it has entered into a definitive merger agreement with Endocare. Under the terms of the agreement, Endocare stockholders can either receive $1.35 per share in cash or 0.7764 shares of HealthTronics stock, subject to certain conditions. The deal is expected to close in the third quarter of 2009. Prior to entering into the agreement with HealthTronics, Endocare terminated its merger agreement with cryotherapy device maker Galil on the grounds that certain closing conditions of the merger could not be fulfilled.

 HealthTronics of Austin, TX, is a premier urology company specializing in surgical lasers and lithotripsy devices. Endocare, based in Irvine, Calif., is a developer of minimally invasive technologies for tissue and tumor ablation. The merger could give both companies’ technology a wider adoption in the urology community.

The comments are closed.